These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6501231)

  • 1. Alteration of Streptococcus pneumoniae membrane properties by the folate analog methotrexate.
    Trombe MC
    J Bacteriol; 1984 Dec; 160(3):849-53. PubMed ID: 6501231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a Streptococcus pneumoniae mutant with altered electric transmembrane potential.
    Trombe MC; Lanéelle G; Sicard AM
    J Bacteriol; 1984 Jun; 158(3):1109-14. PubMed ID: 6233266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entry of methotrexate into Streptococcus pneumoniae: a study on a wild-type strain and a methotrexate resistant mutant.
    Trombe MC
    J Gen Microbiol; 1985 Jun; 131(6):1273-8. PubMed ID: 3876407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the uptake and cytotoxicity of celiptium in wild type and resistant mutants of the bacterium Streptococcus pneumoniae.
    Sautereau AM; Tocanne JF; Trombe MC
    Biochem Biophys Res Commun; 1987 Jun; 145(2):927-33. PubMed ID: 3593380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of delta psi-dependent amino acid transports in Streptococcus pneumoniae by the antitumoral drug SOAz.
    Trombe MC; Beaubestre C; Sautereau AM; Labarre JF; Laneelle G; Tocanne JF
    Biochem Pharmacol; 1984 Sep; 33(17):2749-53. PubMed ID: 6466382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
    Matherly LH; Angeles SM; McGuire JJ
    Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in methotrexate and folate influx in methotrexate-resistant lines of Leishmania major are independent of R or H region amplification.
    Ellenberger TE; Beverley SM
    J Biol Chem; 1987 Oct; 262(28):13501-6. PubMed ID: 3654626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells.
    Zhao R; Seither R; Brigle KE; Sharina IG; Wang PJ; Goldman ID
    J Biol Chem; 1997 Aug; 272(34):21207-12. PubMed ID: 9261128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate.
    van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ
    Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae.
    Kündig C; Haimeur A; Légaré D; Papadopoulou B; Ouellette M
    EMBO J; 1999 May; 18(9):2342-51. PubMed ID: 10228149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.
    Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH
    Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
    Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
    Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 human leukemia cell line.
    Gong M; Yess J; Connolly T; Ivy SP; Ohnuma T; Cowan KH; Moscow JA
    Blood; 1997 Apr; 89(7):2494-9. PubMed ID: 9116294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of the human folate receptor mediates transport-defective methotrexate resistance in KB cells.
    Saikawa Y; Knight CB; Saikawa T; Page ST; Chabner BA; Elwood PC
    J Biol Chem; 1993 Mar; 268(7):5293-301. PubMed ID: 7680349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line.
    Schuetz JD; Matherly LH; Westin EH; Goldman ID
    J Biol Chem; 1988 Jul; 263(20):9840-7. PubMed ID: 2838483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
    Jolivet J; Cole DE; Holcenberg JS; Poplack DG
    Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
    Zhao R; Assaraf YG; Goldman ID
    J Biol Chem; 1998 Apr; 273(14):7873-9. PubMed ID: 9525881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
    J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate mechanisms of antifolate resistance provoked by methotrexate and its metabolite 7-hydroxymethotrexate in leukemia cells: implications for efficacy of methotrexate therapy.
    Fotoohi K; Jansen G; Assaraf YG; Rothem L; Stark M; Kathmann I; Gregorczyk J; Peters GJ; Albertioni F
    Blood; 2004 Dec; 104(13):4194-201. PubMed ID: 15308564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.